Tag: ANDA process

Hatch-Waxman Act Explained: How It Changed Generic Drug Prices and Patents

By : Tamsin Riverton
Date : Jun 9 2026

Discover how the Hatch-Waxman Act revolutionized the US pharmaceutical industry by balancing patent protection for innovators with accelerated approval for generic drugs, drastically lowering medication costs.

ANDA Process: Legal Requirements for Generic Drug Approval in the U.S.

By : Tamsin Riverton
Date : Jan 26 2026

The ANDA process is the legal pathway for generic drug approval in the U.S., governed by the Hatch-Waxman Act. It requires bioequivalence, identical active ingredients, and strict manufacturing standards to ensure safety and affordability.

FDA Generic Drug Approval: Step-by-Step Process for ANDA Submission

By : Tamsin Riverton
Date : Dec 31 2025

Learn the complete step-by-step FDA generic drug approval process through the ANDA pathway, including pharmaceutical equivalence, bioequivalence testing, CMC requirements, and how generics save billions in healthcare costs.